Compositions including an antineoplastically effective amount of a methylol transfer agent (e.g. taurolidine) together with a biodegradable adhesive capable of adhering to tissue of a living subject (e.g. fibrin glue) are useful in treatment for preventing or inhibiting growth of cancer cells.